Inventor · disambiguated record
Mangala Meenakshi Soundarapandian
Also filed as: SOUNDARAPANDIAN MANGALA MEENAKSHI
2 granted patents·14 pending applications·2 citations·filing 2018–2024
43Inventor score
Files withALNYLAM PHARMACEUTICALS INC16
Top patents by PatentIndex Score
16 records- 0190US11993774B2Huntingtin (HTT) iRNA agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2023·Granted May 28, 2024·1 cites·30 claims
- 0282US11034957B2Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Jun 15, 2021·1 cites·30 claims
- 0378US2024425854A1Kisspeptin 1 (kiss1) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0475US2024368594A1Huntingtin (htt) irna agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0570US2023101828A1Kisspeptin 1 (kiss1) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0663US2022002724A1AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0762US2025084417A1Heparin sulfate biosynthesis pathway enzyme irna agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0859US2020385719A1Kisspeptin 1 (kiss1) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0958US2023032974A1SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1058US2024209373A1ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 1 (ELOVL1) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1157US2024011032A1Snca irna compositions and methods of use thereof for treating or preventing snca-associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1256US2024279653A1FOLLICULIN iRNA COMPOSITIONS AND METHODS THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1355US2025283071A1Modified double stranded oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1455US2022380762A1HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1552US2023203486A1MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1650US2023126233A1LEUCINE-RICH REPEAT KINASE 2 (LRRK2) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mangala Meenakshi Soundarapandian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →